NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 130 filers reported holding NOVAVAX INC in Q2 2017. The put-call ratio across all filers is 1.26 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $23,000 | +4.5% | 17,381 | -0.2% | 0.00% | 0.0% |
| Q1 2017 | $22,000 | -57.7% | 17,416 | -57.5% | 0.00% | 0.0% |
| Q4 2016 | $52,000 | -78.2% | 40,944 | -64.4% | 0.00% | -83.3% |
| Q3 2016 | $239,000 | -3.2% | 115,000 | +228.7% | 0.01% | -25.0% |
| Q3 2015 | $247,000 | -8.2% | 34,988 | +44.8% | 0.01% | 0.0% |
| Q2 2015 | $269,000 | -87.3% | 24,158 | -90.6% | 0.01% | -88.2% |
| Q1 2015 | $2,122,000 | +53.1% | 256,588 | -14.5% | 0.07% | +28.3% |
| Q2 2014 | $1,386,000 | +919.1% | 300,000 | +902.0% | 0.05% | +783.3% |
| Q1 2014 | $136,000 | -1.4% | 29,939 | +11.2% | 0.01% | -14.3% |
| Q4 2013 | $138,000 | – | 26,930 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtus ETF Advisers LLC | 265,206 | $329,000 | 0.41% |
| BB BIOTECH AG | 8,330,000 | $10,329,000 | 0.29% |
| QCM Cayman, Ltd. | 25,828 | $32,000 | 0.13% |
| Rock Springs Capital Management LP | 2,000,000 | $2,480,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 1,215,153 | $1,507,000 | 0.09% |
| IHT Wealth Management, LLC | 242,138 | $327,000 | 0.09% |
| Virtu Financial LLC | 1,124,842 | $1,395,000 | 0.07% |
| Telemetry Investments, L.L.C. | 150,000 | $186,000 | 0.07% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 1,023,378 | $1,269,000 | 0.04% |
| CHICAGO EQUITY PARTNERS LLC | 920,900 | $1,142,000 | 0.04% |